Touchstone International Medical Science Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000042J3
CNY
49.49
-0.14 (-0.28%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Positive results in Mar 25

  • RAW MATERIAL COST(Y) Fallen by -4.73% (YoY)
2

With ROE of 12.74%, it has a very attractive valuation with a 4.10 Price to Book Value

3

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 2,357 Million (Small Cap)

stock-summary
P/E

32.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

5.17%

stock-summary
Debt Equity

-0.53

stock-summary
Return on Equity

12.74%

stock-summary
Price to Book

4.10

Revenue and Profits:
Net Sales:
90 Million
(Quarterly Results - Jun 2025)
Net Profit:
35 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.94%
0%
-9.94%
6 Months
86.12%
0%
86.12%
1 Year
150.84%
0%
150.84%
2 Years
118.21%
0%
118.21%
3 Years
122.63%
0%
122.63%
4 Years
94.08%
0%
94.08%
5 Years
33.97%
0%
33.97%

Touchstone International Medical Science Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
11.30%
EBIT Growth (5y)
12.85%
EBIT to Interest (avg)
31.06
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.62
Sales to Capital Employed (avg)
0.46
Tax Ratio
5.78%
Dividend Payout Ratio
153.85%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
26.50%
ROE (avg)
8.12%
Valuation key factors
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
4.10
EV to EBIT
36.39
EV to EBITDA
30.22
EV to Capital Employed
7.67
EV to Sales
7.00
PEG Ratio
0.54
Dividend Yield
5.17%
ROCE (Latest)
21.08%
ROE (Latest)
12.74%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 24.27% vs 7.29% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 100.00% vs 17.45% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "89.60",
          "val2": "72.10",
          "chgp": "24.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "31.10",
          "val2": "17.70",
          "chgp": "75.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.60",
          "val2": "2.30",
          "chgp": "-73.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "35.00",
          "val2": "17.50",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "314.20%",
          "val2": "210.00%",
          "chgp": "10.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 7.71% vs 9.06% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 9.73% vs 9.49% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "269.70",
          "val2": "250.40",
          "chgp": "7.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "56.70",
          "val2": "41.50",
          "chgp": "36.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.20",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.90",
          "val2": "4.10",
          "chgp": "-146.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "51.90",
          "val2": "47.30",
          "chgp": "9.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "170.70%",
          "val2": "126.40%",
          "chgp": "4.43%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
89.60
72.10
24.27%
Operating Profit (PBDIT) excl Other Income
31.10
17.70
75.71%
Interest
0.10
0.00
Exceptional Items
0.60
2.30
-73.91%
Consolidate Net Profit
35.00
17.50
100.00%
Operating Profit Margin (Excl OI)
314.20%
210.00%
10.42%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 24.27% vs 7.29% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 100.00% vs 17.45% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
269.70
250.40
7.71%
Operating Profit (PBDIT) excl Other Income
56.70
41.50
36.63%
Interest
0.40
0.20
100.00%
Exceptional Items
-1.90
4.10
-146.34%
Consolidate Net Profit
51.90
47.30
9.73%
Operating Profit Margin (Excl OI)
170.70%
126.40%
4.43%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 7.71% vs 9.06% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 9.73% vs 9.49% in Dec 2023

stock-summaryCompany CV
About Touchstone International Medical Science Co., Ltd. stock-summary
stock-summary
Touchstone International Medical Science Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available